Improved response with post-ASCT consolidation by low dose thalidomide, cyclophosphamide and dexamethasone as first line treatment for multiple myeloma.

Iftekhar Khan

Improved response with post-ASCT consolidation by low dose thalidomide, cyclophosphamide and dexamethasone as first line treatment for multiple myeloma.

Population & Patient Health

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Original language	English
Journal	British Journal of Haematology
Publication status	Published - 1 Aug 2012

Cite this

@article{c5be303c8a1742a785aa2239fe720ebb,

title = "Improved response with post-ASCT consolidation by low dose thalidomide, cyclophosphamide and dexamethasone as first line treatment for multiple myeloma.",

author = "Iftekhar Khan",

year = "2012",

month = aug,

day = "1",

language = "English",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell Publishing Ltd",

}